Billionaire physician-entrepreneur Patrick Soon-Shiong seems to be orchestrating an entire M&A ecosystem within his own entities.
Two more Nant companies reporting mega-funding: NantOmics has raised $150 million and NantCell has raised $100 million, both from a single investor, according to two SEC filings (here and here). These startups fall under the umbrella company NantWorks that was launched by Soon-Shiong in Los Angeles in 2011.
Research involving editing the human genome, including research with human embryos, is essential to gain basic understanding of biology and germ cells and should be permitted, according to one of the first global meetings to debate the controversial new techniques.
The bold statement was published today (Thursday, Sept. 10) by the Hinxton Group, a global network of stem cell researchers, bioethicists, and experts on policy and scientific publishing, who met in Manchester, England, September 3–4.
Six new research professorships have been endowed with $14.9 million in private donations and state funding, the Maryland Department of Business and Economic Development (DBED) announced Wednesday. The state funds were committed through the Maryland E-Nnovation Initiative, which matches private donations to universities for basic and applied research in scientific and technical fields.
The University of Maryland, College Park; University of Maryland Baltimore; and Johns Hopkins University each received $2.1 million through the program to be split among a pair of new professorships at each school.
AstraZeneca, in a move to increase its biologics manufacturing capacity in the United States, has acquired a high-tech biologics bulk manufacturing plant in Boulder, Colo., from Amgen Inc.
MedImmune, the global biologics research and development arm of AstraZeneca, and Cancer Research UK today said they have opened a new laboratory focused on the discovery and development of new biologic cancer treatments and diagnostics.
The CRUK-MEDI Alliance Laboratory in Cambridge, UK, on Granta Park, was opened this week by UK Life Sciences Minister George Freeman, MP. The new lab reflects an alliance involving MedImmune, Cancer Research UK, and its commercialization and development subsidiary Cancer Research Technology.
University System of Maryland (USM) schools once again have been recognized among the nation’s top universities in recent rankings by multiple publications.
The U.S. News & World Report 2016 edition of America’s Best Colleges released this month recognizes several USM institutions for academic excellence.
Johns Hopkins Kimmel Cancer Center on Thursday will break ground on its planned $100 million, 184,00-square-foot cancer center.
The Skip Viragh Outpatient Cancer Building, named for Maryland mutual fund investment leader and former Hopkins patient Albert P. “Skip” Viragh Jr., is expected to open in 2017 at the northeast corner of Fayette Street and North Broadway. Hopkins first announced the project in May 2014.
After more than a year, MOVE continues to bring business to the county
The MOVE program continues to offer financial incentives to companies moving to Montgomery County a little more than a year after it was inaugurated. The county launched the program in February 2014 following its announcement by County Executive Isiah Leggett. It was actively marketed on both the our websites, through direct mail, with digital and print ads, along with a radio advertising campaign.
The first company to take advantage of the program was computer pioneer L-Soft. In October 2014, L-Soft’s Founder and CEO Eric Thomas moved his company’s operation from Virginia to Montgomery County.
Global venture capital firm New Enterprise Associates, Inc. (NEA) today announced the appointment of Stephen Oesterle, MD, as Venture Partner. Dr. Oesterle is a former Senior Vice President for Medtronic, Inc., the world’s largest medical device company, and brings to NEA more than two decades of experience spanning health technology investment, corporate strategy, and general management.
“Dr. Oesterle is one of the most widely known and respected leaders in the medical device industry, and it is an honor to welcome him to the NEA team,” said Dr. Josh Makower, NEA General Partner and founder of several medical device companies. “Steve brings with him a vast global network of relationships across the academic, technical, clinical, entrepreneurial, and venture communities. His experience in the health technology investment space coupled with his business development and general management background will be invaluable resources to the companies in our portfolio and to the NEA partnership.”
On September 11, 2015, at 10 a.m. the University of Maryland’s (UMD) Department of Electrical and Computer Engineering (ECE), in the A. James Clark School of Engineering, will celebrate the opening of the Texas Instruments Discovery Lab, where first-year engineering students are being exposed to basic electrical and computer engineering concepts in a revolutionary, hands-on way. This lab opening at UMD is part of a company-level commitment by Texas Instruments Incorporated (TI) to ensure young engineering students are engineering- and industry-ready by inspiring them at the inception of their academic careers.
The Texas Instruments Discovery Lab is the setting for a unique approach to engineering curriculum. The Lab will house “ENEE 101: What’s Cool in ECE.” This course, being piloted this semester, is an introductory course meant to anchor students in the A. James Clark School’s electrical and computer engineering program. ENEE 101 features hands-on activities that highlight the role of electrical and computer engineering in the real world. Required for all incoming freshman students, it will allow them to understand the relevance of the technical subjects they will study and their relationship to the profession.
